Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

HGF/SF increases skin melanocytes but doesn't change melanin type or amount.

Most people using minoxidil for hair loss probably won't see significant improvement.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Liquorice and Indian jujube root extracts don't help in fighting male pattern baldness.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Medical terms make new health issues seem more serious but don't affect views on well-known conditions.

The SAFE System may improve hair transplant results but isn't suitable for everyone.

Most tinea capitis cases in Rotterdam were caused by Trichophyton violaceum, mainly affecting Moroccan immigrant children.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Hair's internal fibers are arranged in a pattern that doesn't let much water in, and treatments like oils and heat change how much water hair can absorb.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

Current automatic metrics for long-form question answering don't align with human preferences; a multi-faceted evaluation approach is needed.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.